These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21492498)

  • 21. Psychosis of Alzheimer disease: validity of the construct and response to risperidone.
    Schneider LS; Katz IR; Park S; Napolitano J; Martinez RA; Azen SP
    Am J Geriatr Psychiatry; 2003; 11(4):414-25. PubMed ID: 12837670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using risperidone for Alzheimer's dementia-associated psychosis.
    McNeal KM; Meyer RP; Lukacs K; Senseney A; Mintzer J
    Expert Opin Pharmacother; 2008 Oct; 9(14):2537-43. PubMed ID: 18778191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline Predictors of Antipsychotic Treatment Continuation and Response at Week 8 in Patients with Alzheimer's Disease with Psychosis or Aggressive Symptoms: An Analysis of the CATIE-AD Study.
    Nagata T; Nakajima S; Shinagawa S; Plitman E; Nakayama K; Graff-Guerrero A; Mimura M
    J Alzheimers Dis; 2017; 60(1):263-272. PubMed ID: 28800334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease.
    Rosenheck RA; Leslie DL; Sindelar JL; Miller EA; Tariot PN; Dagerman KS; Davis SM; Lebowitz BD; Rabins P; Hsiao JK; Lieberman JA; Schneider LS;
    Arch Gen Psychiatry; 2007 Nov; 64(11):1259-68. PubMed ID: 17984395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease.
    Mintzer JE
    J Clin Psychiatry; 2001; 62 Suppl 21():23-5. PubMed ID: 11584984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of risperidone on behavioral and psychological symptoms associated with dementia in clinical practice.
    Kurz A; Schwalen S S; Schmitt A
    Int Psychogeriatr; 2005 Dec; 17(4):605-16. PubMed ID: 16185378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design.
    Devanand DP; Mintzer J; Schultz S; Sultzer D; de la Pena D; Gupta S; Colon S; Schimming C; Pelton GH; Andrews H; Levin B
    Am J Geriatr Psychiatry; 2012 Apr; 20(4):362-73. PubMed ID: 21407047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study.
    Lim HK; Kim JJ; Pae CU; Lee CU; Lee C; Paik IH
    Neuropsychobiology; 2010; 62(2):81-6. PubMed ID: 20523078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations.
    Patel AN; Lee S; Andrews HF; Pelton GH; Schultz SK; Sultzer DL; Mintzer J; de la Pena D; Gupta S; Colon S; Schimming C; Levin B; Devanand DP
    Am J Psychiatry; 2017 Apr; 174(4):362-369. PubMed ID: 27855483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine and risperidone treatment of psychosis in Parkinson's disease.
    Ellis T; Cudkowicz ME; Sexton PM; Growdon JH
    J Neuropsychiatry Clin Neurosci; 2000; 12(3):364-9. PubMed ID: 10956570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living.
    Yoon JS; Kim JM; Lee H; Shin IS; Choi SK
    Hum Psychopharmacol; 2003 Dec; 18(8):627-33. PubMed ID: 14696022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized controlled trial of aripiprazole versus risperidone for the treatment of amphetamine-induced psychosis.
    Farnia V; Shakeri J; Tatari F; Juibari TA; Yazdchi K; Bajoghli H; Brand S; Abdoli N; Aghaei A
    Am J Drug Alcohol Abuse; 2014 Jan; 40(1):10-5. PubMed ID: 24359506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Quetiapine and Risperidone in Treatment of Acute Psychosis: A Double-Blind, Randomized-Controlled Study.
    Moosavi SM; Ahmadi M; Mojtahedi D; Yazdani J; Monajemi MB
    Glob J Health Sci; 2015 Jun; 7(5):359-63. PubMed ID: 26156901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design.
    Devanand DP; Strickler JG; Huey ED; Crocco E; Forester BP; Husain MM; Vahia IV; Andrews H; Wall MM; Pelton GH
    Contemp Clin Trials; 2018 Aug; 71():33-39. PubMed ID: 29859917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.